Thursday, April 8, 2021

Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drug

Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drug Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2PNTqR0
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Market moves driven more by psychology than fundamentals: Samir Arora

Indian stock markets are caught between global worries and strong domestic company profits. Foreign investor activity, oil price swings, and...